medigraphic.com
ISSN 0188-2198 (Impreso)

2011, Número 4

<< Anterior Siguiente >>

Rev Mex Cardiol 2011; 22 (4)


Alteraciones cardiacas en pacientes con lupus eritematoso sistémico y sospecha clínica de miocarditis: diagnóstico por resonancia magnética cardiovascular

Rosales USG, Castellanos CL, Galindo UJ, Colín RE, Delgado HRD, Vázquez LJ, Morelos GM

Idioma: Español
Referencias bibliográficas: 40
Paginas: 167-174
Archivo PDF: 144.45 Kb.


RESUMEN

La resonancia magnética cardiovascular (RMC) permite una evaluación integral en pacientes con lupus eritematoso sistémico (LES) y sospecha clínica de miocarditis ya que evalúa parámetros anatómico-funcionales, afectación del pericardio y caracterización del miocardio detectando áreas de inflamación o necrosis, siendo útil para el diagnóstico de miocarditis aguda. El objetivo de este estudio fue identificar alteraciones cardiacas en pacientes con LES y sospecha clínica de miocarditis. Se estudió un total de nueve pacientes portadores de LES, los cuales cumplieron los criterios para este diagnóstico, según el American College of Rheumatology (ACR), con edad promedio de 40.5 años; el 89% fueron mujeres, encontrando disminución de la fracción de eyección del ventrículo izquierdo (FEVI) en el 56% de los pacientes, alteraciones de la contractilidad en el 78%, afectación de alguna de las válvulas cardiacas en el 100%, derrame pericárdico de cualquier grado en el 66%, y lesiones sugestivas de miocarditis en el 44%. La RMC permite en este grupo de pacientes la detección de lesión pericárdica valvular y daño del miocárdico, por lo que este método debe ser considerado ideal para la evaluación y seguimiento de estos pacientes


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR. Systemic lupus erythematosus. Lancet 2001; 357: 1027-1032.

  2. Kong T, Kellum R, Haserick J. Clinical Diagnosis of Cardiac Involvement in Systemic Lupus Erythematosus. Circulation 1962; 26; 7-11.

  3. Mandell BF, Hoffman GS. Rheumatic diseases and the cardiovascular system. En: Braunwald E, Zipes DP, Libby P, Bonow R. 7a Ed. Braunswald’s Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2004, 2110-2112.

  4. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieris S, Hanley J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sánchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A. The development and initial validation of the Systemic Lupus Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.

  5. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980; 69: 849-858.

  6. Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, Crow MK, Sammaritano L, Levine DM, Shanker BA, Moeller E, Salmon JE. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005; 46: 1-6.

  7. Farzaneh-Far A, Roman MJ, Lockshin, MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 54: 3918-3925.

  8. Gross L: Cardiac lesions in Libman-Sacks disease with consideration of its relationship to acute lupus erythematosus. Am J Pathol 1940; 16: 375-408.

  9. Doherty NE, Feldman G, Maurer G, Siegel RJ. Echocardiographic findings in systemic lupus erythematosus. Am J Cardiol 1988; 61: 1144.

  10. Crozier IG, Li E, Milne MJ, Nicholls GM. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990; 65: 1145-1148.

  11. Leung WH, Wong KL, Lau CH, Wong CK, Cheng CH, Tai YT. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus. Am Heart J 1990; 120: 82-87.

  12. Kalke S, Balakrishanan, Mangat G, Mittal G, Kumar N, Joshi VR. Echocardiography in systemic lupus erythematosus. Lupus 1998; 7: 540-544.

  13. Pieretti J, Roman M, Devereux R, Lockshin M, Crow M, Paget S, Schwartz J, Sammaritano L, Levine D, Salomon J. Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass. Circulation 2007; 116: 419-426.

  14. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, antiphospholipid syndrome and neonatal lupus; Rheumatology 2006; 45(Suppl 4): iv8-iv13.

  15. Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 2005; 14: 827-831.

  16. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002; 113: 419-423.

  17. Jacobs JC, Rosen JM, Szer IS. Lyme myocarditis diagnosed by gallium scan. J Pediatr 1984; 105: 950-952.

  18. Yasuda T, Palacios IF, Dec Gw, et al. Indium 111 monoclonal antimyosin antibody amigind in the diagnosis of acute myocarditis. Circulation 1987; 76: 306-311.

  19. Carrio I, Berna L, Ballester M et al. Indium 111 antimyosin scintigraphy to asses myocardial damage in patients with suspected myocarditis and cardiac reyectios. J Nucl Med 1988; 29: 1983-1900.

  20. Gagliardi MG, Bevilacqua M, DiRenzi P, Picardo S, Passariello R, Marcellentti C. Usefulness of magnetic resonance imaging of diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 1991; 68: 1089-1091.

  21. Gagliardi MG, Polletta B, DiRenzi P. MRI for the diagnosis and follow up of myocarditis. Circulation 1999; 99: 458-459.

  22. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998; 97: 1802-1809.

  23. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock T, Klingel K, Kandolf R, Sechtem U. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis. Circulation 2006; 114: 1581-1590.

  24. Roditi GH, Hartnell GG, Cohen MC. MRI change in myocarditis evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging. Cli Radiol 2000; 55: 752-758.

  25. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002; 122: 1638-1648.

  26. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250-1258.

  27. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822.

  28. Wagner A, Schulz-Menger J, Dietz R, Friedrich MG. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. Magma 2003; 16: 17-20.

  29. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-890.

  30. Liu PP, Yan AT. Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol 2005; 45: 1823-1825.

  31. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Cardiovascular magnetic resonance assessment of non-ischemic cardiomyopathies. Eur Heart J 2005; 26: 1461-1474.

  32. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411-419.

  33. Dill T. Ekinci O, Hansel J, Kluge A, Breindenbach C, Hamm C. Delayed contrast enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up. J Cardiovasc Mag Reson 2005; 7: 521-523.

  34. Cervera R, Font J, Pare C, Azqueta M, Pérez-Villa F, López-Soto A, Ingelmo M. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 156-159.

  35. Wang ZJ, Reddy GP, Gotway MB, et al. CT and MR imaging of pericardial disease. Radiographics 2003; 23: 167-180.

  36. Refsum H, Junemann M, Lipton MJ, et al. Ventricular diastolic pressure-volume relations and the pericardium. Effects of changes in blood volume and pericardial effusion in dogs. Circulation 1981; 64: 997-1004.

  37. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.

  38. El-Magadmi M, Bodill H, Ahmad Y, Durrington P, Mackness M, Walter M, Bernstein R, Bruce I, Systemic Lupus Erythematosus. An independent risk factor for endothelial dysfunction in women; Circulation 2004; 110: 399-404.

  39. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D’Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J. Epidemiol 1997; 145: 408-415.

  40. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, Witztum JL, Frostegard J. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893.




2020     |     www.medigraphic.com